A Phase Ib Randomized, Placebo-Controlled Clinical Trial to Study the Safety and Bronchodilatory Effect of MK0476 in Patients With Chronic Asthma.

Trial Profile

A Phase Ib Randomized, Placebo-Controlled Clinical Trial to Study the Safety and Bronchodilatory Effect of MK0476 in Patients With Chronic Asthma.

Completed
Phase of Trial: Phase I

Latest Information Update: 12 Apr 2017

At a glance

  • Drugs Montelukast (Primary) ; Salbutamol
  • Indications Asthma
  • Focus Therapeutic Use
  • Sponsors Merck & Co
  • Most Recent Events

    • 14 Apr 2010 Actual patient number changed from 64 to 68 as reported by ClinicalTrials.gov.
    • 05 Feb 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 22 Jan 2009 Actual initiation date changed from Jun 2008 to Jul 2008 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top